Acrivon Therapeutics to Present at the TD Cowen 46th Annual Health Care Conference Feb 24, 2026 08:00AM
TD Cowen Reiterates Buy Rating on Acrivon Therapeutics Inc (ACRV) Sep 16, 2024 08:42AM
TD Cowen Reiterates Buy Rating on Acrivon Therapeutics Inc (ACRV) Mar 28, 2024 02:04PM
Acrivon Therapeutics Appoints Santhosh Palani, Ph.D., CFA, Experienced Board Member and Healthcare Investor, to its Board of Directors Mar 4, 2024 08:00AM
Acrivon Therapeutics to Participate in a Panel Discussion at the TD Cowen 44th Annual Health Care Conference Feb 27, 2024 08:00AM


Feb 27, 2023 08:00AM Acrivon Therapeutics to Participate on a Panel at Cowen’s 43rd Annual Health Care Conference
Feb 27, 2023 08:00AM Acrivon Therapeutics to Participate on a Panel at Cowen’s 43rd Annual Health Care Conference
Nov 15, 2022 11:09AM Acrivon Therapeutics (ACRV) Opens Up 7%
Nov 15, 2022 05:44AM Acrivon Therapeutics (ACRV) Prices 7.55M Share IPO at $12.50/sh
Nov 14, 2022 10:16PM Acrivon Therapeutics Announces Pricing of Initial Public Offering
Nov 14, 2022 10:16PM Acrivon Therapeutics Announces Pricing of Initial Public Offering
Oct 17, 2022 05:02PM Acrivon Therapeutics (ACRV) Announces Proposed IPO